By Sriparna Roy and Joel Jose (Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts ...

Eli Lilly and Company and Purdue University are keeping their partnership alive beyond it’s previously expected years. In an ...

President Trump plans to sign an executive order mandating drugmakers to align U.S. drug prices with those of other countries ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.

The Danish multinational said that Sogroya improved the yearly growth rate in pre-pubertal children born small for ...

Trump’s “most-favoured nation” drug pricing plan shakes pharma markets, sparking losses for US and EU firms amid uncertainty.